Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
Sponsor: University Hospital, Brest
Summary
The value of 4D body-to-whole dynamic acquisition in FDG PET / CT to differentiate progression / pseudo-progression during the first therapeutic assessment (PET1) of metastatic melanoma treated with immune checkpoint inhibitors (ICI)to predict the progression of the disease..
Official title: Interest in PET/CT Whole-body Dynamic Acquisition at FDG to Differentiate Progression/Pseudo Progression of Metastatic Melanoma Under Immunotherapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
56
Start Date
2020-06-26
Completion Date
2026-06-26
Last Updated
2024-06-26
Healthy Volunteers
No
Conditions
Interventions
value of 4D body-to-whole dynamic acquisition in FDG
differentiate pseudo-progression / progression during the first therapeutic assessment by FDG PET / CT (PET1) using data from the 4D whole-body dynamic acquisition, without having to re-evaluate closely. during a PET1 'this "unconfirmed progression" after 2 new treatment cures of ICI
Locations (1)
Hospital University ff Brest
Brest, Finistere, France